SEBASTIANI, MARCO
 Distribuzione geografica
Continente #
AS - Asia 8.756
NA - Nord America 4.727
EU - Europa 2.063
SA - Sud America 1.918
AF - Africa 572
OC - Oceania 7
AN - Antartide 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.047
Nazione #
US - Stati Uniti d'America 4.476
SG - Singapore 4.163
BR - Brasile 1.425
VN - Vietnam 1.310
CN - Cina 882
HK - Hong Kong 835
BD - Bangladesh 767
IT - Italia 760
ZA - Sudafrica 386
NL - Olanda 359
FR - Francia 321
IN - India 169
AR - Argentina 166
RU - Federazione Russa 155
IQ - Iraq 102
DE - Germania 94
EC - Ecuador 92
CA - Canada 90
MX - Messico 85
GB - Regno Unito 79
CO - Colombia 74
PH - Filippine 54
PK - Pakistan 52
TR - Turchia 52
ID - Indonesia 50
VE - Venezuela 48
UZ - Uzbekistan 42
PL - Polonia 38
AT - Austria 37
PY - Paraguay 37
MA - Marocco 36
JP - Giappone 33
SA - Arabia Saudita 33
MY - Malesia 30
KE - Kenya 29
SE - Svezia 28
IE - Irlanda 27
ES - Italia 26
EG - Egitto 25
PE - Perù 23
CL - Cile 22
TN - Tunisia 22
UA - Ucraina 21
DZ - Algeria 19
FI - Finlandia 19
UY - Uruguay 18
CR - Costa Rica 17
JO - Giordania 16
TH - Thailandia 15
ET - Etiopia 14
LT - Lituania 14
IR - Iran 13
AE - Emirati Arabi Uniti 12
JM - Giamaica 12
TW - Taiwan 12
AZ - Azerbaigian 11
HN - Honduras 11
IL - Israele 11
BO - Bolivia 10
CH - Svizzera 10
KZ - Kazakistan 10
LB - Libano 9
PS - Palestinian Territory 9
KR - Corea 8
NP - Nepal 8
RO - Romania 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
GR - Grecia 7
HU - Ungheria 7
OM - Oman 7
QA - Qatar 7
SN - Senegal 7
BE - Belgio 6
NI - Nicaragua 6
AL - Albania 5
AU - Australia 5
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
CI - Costa d'Avorio 5
LY - Libia 5
PA - Panama 5
PT - Portogallo 5
RS - Serbia 5
AO - Angola 4
GA - Gabon 4
GE - Georgia 4
GH - Ghana 4
MN - Mongolia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
GT - Guatemala 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TL - Timor Orientale 3
AF - Afghanistan, Repubblica islamica di 2
Totale 18.001
Città #
Singapore 1.698
San Jose 1.311
Hong Kong 803
Boardman 456
Ho Chi Minh City 428
Ashburn 426
Santa Clara 373
Dallas 371
Johannesburg 341
Hanoi 303
Lauterbourg 285
Beijing 209
Los Angeles 167
New York 149
São Paulo 121
Moscow 118
Buffalo 100
Milan 80
Rome 60
Columbus 59
Council Bluffs 57
Haiphong 49
Da Nang 45
Baghdad 43
Rio de Janeiro 38
Tashkent 38
Hefei 37
Nuremberg 36
Belo Horizonte 34
Quito 33
Brooklyn 32
Biên Hòa 29
Mexico City 29
Warsaw 28
Brasília 27
Naples 27
Shanghai 27
Dublin 26
Hải Dương 26
Toronto 26
Chennai 25
Curitiba 24
Guayaquil 24
Munich 23
Chicago 22
Dhaka 22
Guangzhou 22
Medellín 22
Turin 22
Tokyo 21
Assago 20
Phoenix 20
Stockholm 20
Atlanta 19
Charlotte 19
Nairobi 19
San Francisco 19
Vienna 19
Caracas 18
Fortaleza 18
Frankfurt am Main 18
Kuala Lumpur 18
Orem 18
Amsterdam 17
Asunción 17
Bologna 17
Can Tho 17
Manaus 17
Montreal 17
Istanbul 16
Thái Bình 16
Cape Town 15
Guarulhos 15
Montevideo 15
Bogotá 14
Boston 14
Campinas 14
Erbil 14
Ninh Bình 14
Parma 14
Salvador 14
Secaucus 14
Addis Ababa 13
Buenos Aires 13
London 13
Porto Alegre 13
Amman 12
Bari 12
Casablanca 12
Lahore 12
Recife 12
Riyadh 12
Chandler 11
Hangzhou 11
Palermo 11
Turku 11
Baku 10
Bắc Ninh 10
Florianópolis 10
Goiânia 10
Totale 9.516
Nome #
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 104
Updated systematic literature review and meta-analysis to inform the Italian Society of Rheumatology Recommendations on the treatment of rheumatoid arthritis-associated interstitial lung disease 103
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 102
PREVALENCE, INCIDENCE AND SURVIVAL IN INTERSTITIAL LUNG DISEASE SECONDARY TO PRIMARY SJOGREN'S SYNDROME. RESULTS FROM THE "EMERGE" LONGITUDINAL STUDY 99
The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases 99
Efficacy and safety of mepolizumab in eosinophilic granulomatosis with polyangiitis: Insights from real-life cases and literature analysis 98
Interstitial lung disease in Sjögren's syndrome: a clinical review 94
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 92
COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey 92
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 92
Anti-TNF Therapy Is Not Associated with an Increase in Neoplasias in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry 90
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 89
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 86
Aortic pulse wave velocity measurement in systemic sclerosis patients 85
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases 84
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 84
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 83
PROGRESSIVE MICROVASCULAR ABNORMALITIES DETECTABLE OVERTIME BY NAILFOLD VIDEOCAPILLAROSCOPY IN LONG-COVID PATIENTS: A MULTICENTER ITALIAN INVESTIGATION 83
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 83
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 82
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 81
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 81
RADIOLOGIC AND SEROLOGIC FEATURES IN PATIENTS WITH INTERSTITIAL LUNG DISEASE SECONDARYTO SJOGREN'S SYNDROME. COLLABORATIVE STUDY OF ISLAND (ITALIAN STUDY GROUP ON LUNG INVOLVEMENT IN RHEUMATIC DISEASES) AND GRISS (GRUPPO DI RICERCA ITALIANO SULLA SINDROME DI SJÖGREN) STUDY GROUP OF SIR (ITALIAN SOCIETY OF RHEUMATOLOGY) 81
Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications 81
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 80
Prevention of Digital Ulcers in Systemic Sclerosis Patients: A Proposal of Risk Chart 80
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 80
Rheumatoid arthritis related interstitial lung disease 80
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 79
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 78
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 78
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature 77
Acute exacerbation of interstitial lung disease associated with rheumatic disease 77
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 77
Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries 76
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 75
RADIOMICS AND MACHINE LEARNING FOR DIFFERENTIATING RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS WITH USUAL INTERSTITIAL PNEUMONIA PATTERN 75
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection 75
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 74
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 74
Lung complications of Sjogren syndrome 74
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 73
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 73
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 73
Validation of the classification criteria for cryoglobulinaemic vasculitis 73
A new chance to treat rheumatoid arthritis lung fibrosis? 72
A modified Delphi exercise in physician-perceived risk factors for drug-induced pneumotoxicity in patients with rheumatological disease 72
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 72
REAL-WORLD EFFECTIVENESS OF UPADACITINIB ACROSS DIFFERENT CLINICAL PHENOTYPES IN A LARGE ITALIAN PSA COHORT 72
Clinical and Serological Characteristics of Sjogren's Disease-related Lymphocytic Interstitial Pneumonia: A Large Multicenter Study 72
SEX-BASED DIFFERENCES IN 24-MONTH TREATMENT OUTCOMES WITH B/TS-DMARDS IN PSORIATIC ARTHRITIS: REAL-WORLD EVIDENCE AND PREDICTIVE MODELING FROM THE GRUPPO ITALIANO STUDIO EARLY ARTHRITIS (GISEA) MULTICENTER PROSPECTIVE REGISTRY 71
Procedural pain management in the treatment of scleroderma digital ulcers 71
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 71
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature 70
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists 70
Treatment of HCV-related mixed cryoglobulinemia 69
Anti-TNF Therapy Is Associated with an Increase in Serious Infections in Patients with Spondyloarthritis (SpA), Especially during the First 12 Monts of Treatment: Results from the GISEA Registry 69
Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome 69
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 69
Cardiac Involvement in Systemic Vasculitis 69
Fibrosing interstitial lung disease in primary Sjogren syndrome 69
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 68
Incidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs 67
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 67
La capillaroscopia in reumatologia. Lesioni elementari e metodi di scoring 67
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 67
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib 67
Current treatment of hepatitis C-associated rheumatic diseases 67
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 66
Trattamento con Rituximab in pazienti con vasculite crioglobulinemica 66
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 66
Prevalenza delle epatiti nelle malattie reumatiche 66
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 66
Guiding ILD management in systemic autoimmune rheumatic diseases 66
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement 66
Methotrexate and rheumatoid arthritis associated interstitial lung disease 66
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry 66
Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium” 65
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 65
Validation Study Of The International Classification Criteria For The Cryoglobulinemic Vasculitis 65
POS0374 HOW WELL DO EULAR/ASAS-EULAR AND NATIONAL TREATMENT RECOMMENDATIONS FOR PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS ALIGN? IS IT TIME FOR AN UPDATE OF NATIONAL TREATMENT RECOMMENDATIONS? 65
B-cells and mixed cryoglobulinemia 64
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma 64
Disease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset 64
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 64
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients 64
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 64
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 64
Mixed cryoglobulinemia syndrome: where are we going to? 63
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 63
AN OVERVIEW OF NAILFOLD CAPILLAROSCOPY IN ITALY: RESULTS FROM A NATIONAL SURVEY 63
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 63
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry 62
Interstitial Lung Disease Associated With Autoimmune Rheumatic Diseases: Checklists for Clinical Practice 62
Trattamento con IgIV ad alte dosi in un caso di dermatomiosite con grave disfagia refrattaria alle terapie standard 61
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 61
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 61
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 61
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients 61
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study 61
Totale 7.390
Categoria #
all - tutte 69.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 0 4 0 1 2 0 0 1 7
2022/202343 6 2 2 3 2 7 0 3 15 2 1 0
2023/2024724 5 3 0 0 2 5 0 0 3 337 103 266
2024/20254.669 52 369 322 49 419 293 144 130 708 654 312 1.217
2025/202613.054 752 1.323 1.646 1.037 1.527 435 1.644 361 1.315 1.061 1.345 608
Totale 18.516